A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice

Development and Application of a Multiroute Physiologically Based Pharmacokinetic Model for Oxytetracycline in Dogs and Humans

(2015) Zhoumeng Lin et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus)

(2014) Teresa L. Leavens et al.   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles

(2014) Gerald Bachler et al.   Nanotoxicology

Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats

(2014) Dingsheng Li et al.   Nanotoxicology

The road to nowhere: equilibrium partition coefficients for nanoparticles

(2014) Antonia Praetorius et al.   Environmental Science-Nano

The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles

(2013) Xiangsheng Liu et al.   BIOMATERIALS

Uptake of Engineered Gold Nanoparticles into Mammalian Cells

(2013) Lev A. Dykman et al.   CHEMICAL REVIEWS

Of mice, men and nanoparticle biocoronas: arein vitrotoin vivocorrelations and interspecies extrapolations realistic?

(2013) Jim E Riviere   Nanomedicine

Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling

(2013) Zhoumeng Lin et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches

(2012) Hannah M. Jones et al.   AAPS Journal

Toxico-/biokinetics of nanomaterials

(2012) Robert Landsiedel et al.   ARCHIVES OF TOXICOLOGY

Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future

(2012) Rochelle R. Arvizo et al.   CHEMICAL SOCIETY REVIEWS

Endocytosis at the nanoscale

(2012) Irene Canton et al.   CHEMICAL SOCIETY REVIEWS

Physiologically Based Pharmacokinetic Model for Composite Nanodevices: Effect of Charge and Size on In Vivo Disposition

(2012) Donald E. Mager et al.   PHARMACEUTICAL RESEARCH

Fluorescence-Tagged Gold Nanoparticles for Rapidly Characterizing the Size-Dependent Biodistribution in Tumor Models

(2012) Leo Y. T. Chou et al.   Advanced Healthcare Materials

Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration

(2011) Stephanie Hirn et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells

(2011) Leshuai W Zhang et al.   Nanomedicine

Impact of dietary gold nanoparticles in zebrafish at very low contamination pressure: The role of size, concentration and exposure time

(2011) Benjamin Geffroy et al.   Nanotoxicology

Pharmacokinetic modeling: Prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans

(2011) Jeffrey W. Fisher et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Physiologically Based Pharmacokinetic Modeling of Nanoparticles

(2010) Mingguang Li et al.   ACS Nano

The kinetics of the tissue distribution of silver nanoparticles of different sizes

(2010) D.P.K. Lankveld et al.   BIOMATERIALS

Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies

(2010) Nikolai Khlebtsov et al.   CHEMICAL SOCIETY REVIEWS

Size-dependent tissue kinetics of PEG-coated gold nanoparticles

(2010) Wan-Seob Cho et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice

(2009) Guodong Zhang et al.   BIOMATERIALS

Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats

(2009) Suresh K. Balasubramanian et al.   BIOMATERIALS

Development of a physiologically based kinetic model for 99m-Technetium-labelled carbon nanoparticles inhaled by humans

(2009) Alexandre R. R. Péry et al.   INHALATION TOXICOLOGY

Comparison of Quantum Dot Biodistribution with a Blood-Flow-Limited Physiologically Based Pharmacokinetic Model

(2009) Hyun A. Lee et al.   NANO LETTERS

Understanding biophysicochemical interactions at the nano–bio interface

(2009) Andre E. Nel et al.   NATURE MATERIALS

Mechanisms of Quantum Dot Nanoparticle Cellular Uptake

(2009) Leshuai W. Zhang et al.   TOXICOLOGICAL SCIENCES

Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles

(2009) Wan-Seob Cho et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100nm-sized PEG-coated gold nanoparticles

(2009) Wan-Seob Cho et al.   TOXICOLOGY LETTERS

Computational and Ultrastructural Toxicology of a Nanoparticle, Quantum Dot 705, in Mice

(2008) Pinpin Lin et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model

(2008) Jennifer L. Buur et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots

(2008) Jim E. Riviere   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology